The firings are in addition to the roughly 75,000 workers who have taken a buyout that Trump and Musk have offered to get them to leave voluntarily, which equals about 3% of the 2.3-million-person ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Vertex’s drug works differently, blocking proteins that trigger pain signals that are later sent to the brain. "In trying to develop medicines that don’t have the addictive risks of opioid medicines, ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. This therapy seems likely to become the new standard of care for CF with its powerful efficacy and convenient once-per ...

Chicken poo is a factor in River Wye pollution, which is in turn a factor in housing moratoriums throughout Herefordshire and Powys, MPs have heard (Joe Giddens/PA) Poultry farming creates ...

--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq ... therapeutic and dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) with best-in ...

In a report released today, Atif Malik from Citi upgraded Formfactor (FORM – Research Report) to a Buy, with a price target of $51.00. The company’s shares closed yesterday at $46.12.